STOCK TITAN

Jazz Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference on June 2, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Jazz Pharmaceuticals (Nasdaq: JAZZ) will present at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 1:00 p.m. ET. The management team will discuss the company's business and financial updates. The live webcast will be accessible on the Jazz Pharmaceuticals website, with a replay available for one week.

Jazz Pharmaceuticals is a global biopharmaceutical company focused on developing innovative medicines for patients with serious diseases.

Positive
  • None.
Negative
  • None.

DUBLIN, May 26, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and financial updates at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 1:00 p.m. ET / 6:00 p.m. IST.

Interested parties may access the live webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. A replay of the webcast will be archived on the website for at least one week.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
investorinfo@jazzpharma.com      
Ireland +353 1 634 7887

Media:
Jacqueline Kirby
Vice President, Corporate Affairs & Government Relations
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 697 2141
U.S. +1 215 867 4910

Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-jefferies-virtual-healthcare-conference-on-june-2-2021-301299039.html

SOURCE Jazz Pharmaceuticals plc

FAQ

What is the date of Jazz Pharmaceuticals' presentation at the Jefferies Virtual Healthcare Conference?

Jazz Pharmaceuticals will present on June 2, 2021.

What time will Jazz Pharmaceuticals' presentation take place?

The presentation is scheduled for 1:00 p.m. ET.

Where can I watch Jazz Pharmaceuticals' presentation live?

The live webcast can be accessed on the Jazz Pharmaceuticals website.

How long will the replay of Jazz Pharmaceuticals' presentation be available?

The replay will be available for at least one week after the presentation.

What is the purpose of Jazz Pharmaceuticals' participation in the Jefferies Virtual Healthcare Conference?

The management team will provide an overview of the company and business and financial updates.

Jazz Pharmaceuticals, Inc.

NASDAQ:JAZZ

JAZZ Rankings

JAZZ Latest News

JAZZ Stock Data

7.65B
58.63M
2.94%
98.78%
5.94%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
DUBLIN